AAAAAA

   
Results: 1-13 |
Results: 13
Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII
Authors: Andrews, JL Kadan, MJ Gorziglia, MI Kaleko, M Connelly, S
Citation: Jl. Andrews et al., Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII, MOL THER, 3(3), 2001, pp. 329-336
Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia a mice compared with factor VIII protein infusion
Authors: Bristol, JA Gallo-Penn, A Andrews, J Idamakanti, N Kaleko, M Connelly, S
Citation: Ja. Bristol et al., Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia a mice compared with factor VIII protein infusion, HUM GENE TH, 12(13), 2001, pp. 1651-1661
Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein
Authors: Slosberg, ED Desai, UJ Fanelli, B Denny, IS Connelly, S Kaleko, M Boettcher, BR Caplan, SL
Citation: Ed. Slosberg et al., Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein, DIABETES, 50(8), 2001, pp. 1813-1820
Phenotypic correction of diabetic mice by adenovirus-mediated glucokinase expression
Authors: Desai, UJ Slosberg, ED Boettcher, BR Caplan, SL Fanelli, B Stephan, Z Gunther, VJ Kaleko, M Connelly, S
Citation: Uj. Desai et al., Phenotypic correction of diabetic mice by adenovirus-mediated glucokinase expression, DIABETES, 50(10), 2001, pp. 2287-2295
Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs
Authors: Gallo-Penn, AM Shirley, PS Andrews, JL Tinlin, S Webster, S Cameron, C Hough, C Notley, C Lillicrap, D Kaleko, M Connelly, S
Citation: Am. Gallo-penn et al., Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs, BLOOD, 97(1), 2001, pp. 107-113
In vivo dose threshold effect of adenovirus-mediated Factor VIII cone therapy in hemophiliac mice
Authors: Bristol, JA Shirley, P Idamakanti, N Kaleko, M Connelly, S
Citation: Ja. Bristol et al., In vivo dose threshold effect of adenovirus-mediated Factor VIII cone therapy in hemophiliac mice, MOL THER, 2(3), 2000, pp. 223-232
Frank Schnabel Memorial Lecture - An overview of gene therapy
Authors: Kaleko, M
Citation: M. Kaleko, Frank Schnabel Memorial Lecture - An overview of gene therapy, HAEMOPHILIA, 6, 2000, pp. 9-11
In vivo evaluation of a novel epitope-tagged human factor VIII-encoding adenoviral vector
Authors: Roy, S Shirley, PS Connelly, S Andrews, JL Kayda, DB Gardner, JM Kaleko, M
Citation: S. Roy et al., In vivo evaluation of a novel epitope-tagged human factor VIII-encoding adenoviral vector, HAEMOPHILIA, 5(5), 1999, pp. 340-348
Efficient adenoviral vector transduction and expression of functional human factor VIII in cultured primary human hepatocytes
Authors: Andrews, JL Weaver, L Kaleko, M Connelly, S
Citation: Jl. Andrews et al., Efficient adenoviral vector transduction and expression of functional human factor VIII in cultured primary human hepatocytes, HAEMOPHILIA, 5(3), 1999, pp. 160-168
Adenoviral vector-mediated expression of physiologic levels of human factor VIII in nonhuman primates
Authors: Brann, T Kayda, D Lyons, RM Shirley, P Roy, S Kaleko, M Smith, T
Citation: T. Brann et al., Adenoviral vector-mediated expression of physiologic levels of human factor VIII in nonhuman primates, HUM GENE TH, 10(18), 1999, pp. 2999-3011
In vivo evaluation of an adenoviral vector encoding canine factor VIII: High-level, sustained expression in hemophiliac mice
Authors: Gallo-Penn, AM Shirley, PS Andrews, JL Kayda, DB Pinkstaff, AM Kaloss, M Tinlin, S Cameron, C Notley, C Hough, C Lillicrap, D Kaleko, M Connelly, S
Citation: Am. Gallo-penn et al., In vivo evaluation of an adenoviral vector encoding canine factor VIII: High-level, sustained expression in hemophiliac mice, HUM GENE TH, 10(11), 1999, pp. 1791-1802
Evaluation of an adenoviral vector encoding full-length human factor VIII in hemophiliac mice
Authors: Connelly, S Andrews, JL Gallo-Penn, AM Tagliavacca, L Kaufman, RJ Kaleko, M
Citation: S. Connelly et al., Evaluation of an adenoviral vector encoding full-length human factor VIII in hemophiliac mice, THROMB HAEM, 81(2), 1999, pp. 234-239
Generation of an adenovirus vector lacking E1, E2a, E3, and all of E4 except open reading frame 3
Authors: Gorziglia, MI Lapcevich, C Roy, S Kang, Q Kadan, M Wu, V Pechan, P Kaleko, M
Citation: Mi. Gorziglia et al., Generation of an adenovirus vector lacking E1, E2a, E3, and all of E4 except open reading frame 3, J VIROLOGY, 73(7), 1999, pp. 6048-6055
Risultati: 1-13 |